Clinical Efficacy of New Quinolones for Therapy of Nongonococcal Urethritis
- 1 January 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 16 (1) , 7-10
- https://doi.org/10.1097/00007435-198901000-00002
Abstract
Ninety-five patients with nongonococcal urethritis were enrolled in a double-blind study and were randomly assigned to a one-week treatment with ciprofloxacin (500 mg twice daily) or ofloxacin (200 mg twice daily). Two weeks after treatment the results obtained for the 79 evaluated patients were as follows: 59 patients (75%) were clinically cured, and of the 54 patients with initial positive cultures, 39 (72%) remained culture-negative. We did not find any statistically significant differences between the results obtained with the two treatments. These results did not vary with the cause. Patient compliance with the regimens of two doses per day was excellent, and no serious adverse effects occurred with either drug.This publication has 5 references indexed in Scilit:
- Comparative Clinical Efficacy of Two Different Single-dose Ciprofloxacin Treatments for Uncomplicated GonorrheaSexually Transmitted Diseases, 1986
- Evaluation of ciprofloxacin 500 mg twice daily for one week in treating uncomplicated gonococcal chlamydial, and non-specific urethritis in men.Sexually Transmitted Infections, 1986
- Activities of new quinoline derivatives against genital pathogensAntimicrobial Agents and Chemotherapy, 1985
- The pharmacokinetics and tissue penetration of ofloxacinJournal of Antimicrobial Chemotherapy, 1984
- Differential agar medium (A7) for identification of Ureaplasma urealyticum (human T mycoplasmas) in primary cultures of clinical materialJournal of Clinical Microbiology, 1976